ViroStatics Competitors and Similar CompaniesClear all
ViroStatics's competitors and similar companies include FORMA Therapeutics, Halozyme Therapeutics, Ablynx and PLIVA.
 FORMA Therapeutics FORMA Therapeutics is a biopharmaceutical company intended for the discovery, development, and commercialization of transformative medicines. |  Halozyme Therapeutics Halozyme Therapeutics is a biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment. |  Ablynx Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments. |  PLIVA PLIVA HRVATSKA is a pharmaceutical company focused on the development of generic and niche products. | ||
Founding Date | Founding Date 2005 | Founding Date 2008 | Founding Date 1998 | Founding Date 2001 | Founding Date 1921 |
Type | Type Private | Type Public | Type Public | Type Subsidiary | Type Subsidiary |
Tags | |||||
Locations | Locations Sassari, IT HQ Tramariglio, IT | Locations Watertown, US HQ | Locations San Diego, US HQ | Locations Gent, BE HQ | Locations Zagreb, HR HQ Sarajevo, BA Skopje, MK Belgrade, RS |
Employees | Employees 8 | Employees 77 | Employees 373157% increase | Employees 1252% decrease | Employees 1,685 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 998.7 m | Valuation ($) 6.4 b | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $1.4b (FY, 2025) | Revenue (est.) €85.2m (FY, 2016) | Revenue (est.) N/A |
Net income | Net income N/A | Net income ($173m) (FY, 2021) | Net income $316.9m (FY, 2025) | Net income (€1.1m) (FY, 2016) | Net income N/A |
Operating ⚠ | |||||
Patents (US) | Patents (US) N/A | Patents (US) N/A | Patents (US) 43 (FY, 2020) | Patents (US) 50 (Q2, 2017) | Patents (US) N/A |
Funding | |||||
Total funding raised | Total funding raised $ 53k | Total funding raised $ 142.5m | Total funding raised $ 171.9m | Total funding raised $ 498.8m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
FORMA Therapeutics
HQ
Watertown, US
Employees
77
FORMA Therapeutics is a biopharmaceutical company intended for the discovery, development, and commercialization of transformative medicines.
View companyHalozyme Therapeutics
HQ
San Diego, US
Employees
373
Halozyme Therapeutics is a biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment.
View companyAblynx
HQ
Gent, BE
Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments.
View companyPLIVA
HQ
Zagreb, HR
PLIVA HRVATSKA is a pharmaceutical company focused on the development of generic and niche products.
View company